{"title":"抗菌药物管理计划在医疗保健中的全球影响:有效性、成本效益和实施策略的总括性审查","authors":"Yuvaraj Krishnamoorthy , Dhanajayan Govindan , Monica Karunakaran , Muneera Parveen , Anaswara Manohar , Jaffar A. Al-Tawfiq","doi":"10.1016/j.jiac.2025.102753","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Antimicrobial Stewardship Programs (ASPs) are vital in mitigating global threat of antimicrobial resistance (AMR) by optimizing antibiotic use and improving patient outcomes. Despite available evidence from high-income countries, challenges remain in low- and middle-income countries (LMIC) due to resource constraints and heterogeneous implementation. This umbrella review synthesizes evidence from systematic reviews to assess the effectiveness, cost-effectiveness, and implementation barriers and facilitators of ASPs across diverse healthcare settings.</div></div><div><h3>Methods</h3><div>Following PRIOR guidelines and PROSPERO registration (ID: CRD42024541821), we conducted comprehensive search of PubMed, Scopus, Cochrane Library, Epistemonikos, Google Scholar, and ScienceDirect up to July 2024. Data were extracted using standardized form and methodological quality of reviews was assessed with AMSTAR-2 tool. Given heterogeneity in study designs, outcomes, and ASP interventions, narrative synthesis was employed.</div></div><div><h3>Results</h3><div>The included 55 reviews demonstrated that ASPs consistently reduce antibiotic consumption—achieving reductions up to 91 %—and improve adherence to prescribing guidelines. Significant declines in resistance rates for key pathogens, such as MRSA and ESBL-producing organisms, were reported. Although effects on mortality and hospital length of stay were variable, most studies confirmed substantial cost-savings (up to 82 % reduction in antibiotic expenditures). Implementation barriers primarily included limited resources, insufficient data infrastructure, and prescriber resistance, while strong organizational support and multidisciplinary collaboration emerged as key facilitators.</div></div><div><h3>Conclusion</h3><div>ASPs are both clinically effective and economically advantageous in diverse healthcare settings. Tailored strategies that address local barriers and leverage existing infrastructure are essential for sustainable implementation. Future research should focus on standardized evaluation methods and long-term impacts to further optimize ASP adoption globally.</div></div>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"31 8","pages":"Article 102753"},"PeriodicalIF":1.9000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Global impact of antimicrobial stewardship programs in Healthcare: An umbrella review of effectiveness, cost-efficiency, and implementation strategies\",\"authors\":\"Yuvaraj Krishnamoorthy , Dhanajayan Govindan , Monica Karunakaran , Muneera Parveen , Anaswara Manohar , Jaffar A. Al-Tawfiq\",\"doi\":\"10.1016/j.jiac.2025.102753\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Antimicrobial Stewardship Programs (ASPs) are vital in mitigating global threat of antimicrobial resistance (AMR) by optimizing antibiotic use and improving patient outcomes. Despite available evidence from high-income countries, challenges remain in low- and middle-income countries (LMIC) due to resource constraints and heterogeneous implementation. This umbrella review synthesizes evidence from systematic reviews to assess the effectiveness, cost-effectiveness, and implementation barriers and facilitators of ASPs across diverse healthcare settings.</div></div><div><h3>Methods</h3><div>Following PRIOR guidelines and PROSPERO registration (ID: CRD42024541821), we conducted comprehensive search of PubMed, Scopus, Cochrane Library, Epistemonikos, Google Scholar, and ScienceDirect up to July 2024. Data were extracted using standardized form and methodological quality of reviews was assessed with AMSTAR-2 tool. Given heterogeneity in study designs, outcomes, and ASP interventions, narrative synthesis was employed.</div></div><div><h3>Results</h3><div>The included 55 reviews demonstrated that ASPs consistently reduce antibiotic consumption—achieving reductions up to 91 %—and improve adherence to prescribing guidelines. Significant declines in resistance rates for key pathogens, such as MRSA and ESBL-producing organisms, were reported. Although effects on mortality and hospital length of stay were variable, most studies confirmed substantial cost-savings (up to 82 % reduction in antibiotic expenditures). Implementation barriers primarily included limited resources, insufficient data infrastructure, and prescriber resistance, while strong organizational support and multidisciplinary collaboration emerged as key facilitators.</div></div><div><h3>Conclusion</h3><div>ASPs are both clinically effective and economically advantageous in diverse healthcare settings. Tailored strategies that address local barriers and leverage existing infrastructure are essential for sustainable implementation. Future research should focus on standardized evaluation methods and long-term impacts to further optimize ASP adoption globally.</div></div>\",\"PeriodicalId\":16103,\"journal\":{\"name\":\"Journal of Infection and Chemotherapy\",\"volume\":\"31 8\",\"pages\":\"Article 102753\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-06-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection and Chemotherapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1341321X25001503\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1341321X25001503","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Global impact of antimicrobial stewardship programs in Healthcare: An umbrella review of effectiveness, cost-efficiency, and implementation strategies
Background
Antimicrobial Stewardship Programs (ASPs) are vital in mitigating global threat of antimicrobial resistance (AMR) by optimizing antibiotic use and improving patient outcomes. Despite available evidence from high-income countries, challenges remain in low- and middle-income countries (LMIC) due to resource constraints and heterogeneous implementation. This umbrella review synthesizes evidence from systematic reviews to assess the effectiveness, cost-effectiveness, and implementation barriers and facilitators of ASPs across diverse healthcare settings.
Methods
Following PRIOR guidelines and PROSPERO registration (ID: CRD42024541821), we conducted comprehensive search of PubMed, Scopus, Cochrane Library, Epistemonikos, Google Scholar, and ScienceDirect up to July 2024. Data were extracted using standardized form and methodological quality of reviews was assessed with AMSTAR-2 tool. Given heterogeneity in study designs, outcomes, and ASP interventions, narrative synthesis was employed.
Results
The included 55 reviews demonstrated that ASPs consistently reduce antibiotic consumption—achieving reductions up to 91 %—and improve adherence to prescribing guidelines. Significant declines in resistance rates for key pathogens, such as MRSA and ESBL-producing organisms, were reported. Although effects on mortality and hospital length of stay were variable, most studies confirmed substantial cost-savings (up to 82 % reduction in antibiotic expenditures). Implementation barriers primarily included limited resources, insufficient data infrastructure, and prescriber resistance, while strong organizational support and multidisciplinary collaboration emerged as key facilitators.
Conclusion
ASPs are both clinically effective and economically advantageous in diverse healthcare settings. Tailored strategies that address local barriers and leverage existing infrastructure are essential for sustainable implementation. Future research should focus on standardized evaluation methods and long-term impacts to further optimize ASP adoption globally.
期刊介绍:
The Journal of Infection and Chemotherapy (JIC) — official journal of the Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases — welcomes original papers, laboratory or clinical, as well as case reports, notes, committee reports, surveillance and guidelines from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials are particularly welcome.